Target intelligence / Profile preview

Immunoglobulin lambda variable 7-43 (IGLV7-43)

Target
IGLV7-43
Molecular classification
Immunoglobulin variable region, Antigen-binding domain, Other (component of immunoglobulin light chain; not enzyme, receptor, etc.)
01

Overview

Immunoglobulin lambda variable 7-43 is a protein-encoding gene specifying the variable region of the lambda light chain in human antibodies (immunoglobulins). The antigen specificity of an antibody is determined by the unique sequence and structure of its variable domains, which together with the heavy chain form the antigen-binding site. IGLV7-43 is involved in antigen recognition and humoral immune response and is located in the extracellular region and plasma membrane as part of the immunoglobulin complex produced by B lymphocytes. Abnormal expression or ratios of immunoglobulin light chains, including those encoded by IGLV7-43, can be a biomarker for diseases such as multiple myeloma, lymphomas, and chronic inflammatory conditions[2][3][5][1].

Other names
IGLV7-43Ig lambda chain V region 4AIGLV743V3-2
02

Biological functions

Antigen bindingImmune response (specifically humoral immunity and antigen recognition by antibodies)
03

Disease associations

Cancer (clonal light chain analysis is used for B-cell lymphoma and multiple myeloma diagnostics)Inflammation (polyclonal light chains may increase in inflammatory diseases)Other (component of immune system with implications if abnormal abundance or ratio is found)
04

Biomarkers

Used to assess abnormal clonal populations in blood cancers (e.g., ratio of kappa to lambda light chains)Used in detection of plasma cell dyscrasias (such as multiple myeloma, Bence Jones protein detection)

Beyond the preview

Go deeper on Immunoglobulin lambda variable 7-43 (IGLV7-43).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable 7-43 (IGLV7-43).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call